# Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder

> **NCT00399763** · NA · COMPLETED · sponsor: **Denver Health and Hospital Authority** · enrollment: 70 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder
- Substance Abuse

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00399763
- **Lead sponsor:** Denver Health and Hospital Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2015-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399763, "Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00399763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*